AL Amyloidosis Clinical Trial
Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation
Summary
This study examines the value of stem cell transplantation in managing light chain amyloidisis.
Full Description
How does age at diagnosis affect prognosis in primary amyloidosis?
How do lab values at diagnosis such as Creatinine, AST/ALT, total serum protein, serum gamma globulin/immunoglobulin levels affect prognosis in primary amyloidosis?
How does degree of organ involvement/number of organs involved affect prognosis in primary amyloidosis?
How does initial treatment affect prognosis in primary amyloidosis?
4. How do the specifics the stem cell transplant protocol affect prognosis in primary amyloidosis?
Eligibility Criteria
Inclusion Criteria:
Eligible for Stem cell transplantation less than age 75
Exclusion Criteria:
Creatinine > 3.0
BNP > 10000
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Rochester Minnesota, 55905, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.